Physician

Michael D Kohen, M.D.

According to 2025 Medicare claims, Michael Kohen, M.D. (NPI: 1013909951) practices allergy/immunology in the Deltona-Daytona Beach-Ormond Beach, FL market, with the plurality of this provider's patient population coming from Volusia, FL. This provider's primary affiliated billing organization is MICHAEL D. KOHEN, MD, PA (NPI: 1679772446; TIN: 591641576) and primary practice location at 32114-1603. Kohen is affiliated with the Caravan Health ACO 50 LLC (ACO ID: A5160), participating under the MSSP model.

Kohen's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 739 traditional Medicare patients, billed 200,024 HCPCS/CPT codes, and received $987,436 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 5,276 prescription claims across 845 beneficiaries totaling $2,338,900 in drug costs, led by Xeljanz Xr (Tofacitinib Citrate). 2023 DME data shows 30 claims. Open Payments data shows 323 records totaling $401,284. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $363,069 to $987,436. Concurrently, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $2,788 to $395.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,052	28,107	$363,069
2016	1,091	37,946	$391,903
2017	853	39,426	$401,364
2018	912	37,332	$428,056
2019	896	60,123	$580,380
2020	849	83,021	$734,990
2021	812	132,815	$1,010,879
2022	813	162,538	$977,952
2023	791	186,150	$985,074
2024	739	200,024	$987,436

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	1,171	9,608	$1,923,865
2016	1,177	9,586	$2,286,952
2017	1,179	8,774	$2,050,297
2018	1,079	6,789	$1,895,789
2019	970	6,333	$2,276,456
2020	983	6,813	$2,581,451
2021	1,010	6,429	$2,531,448
2022	989	6,145	$2,691,091
2023	918	5,591	$2,652,538
2024	845	5,276	$2,338,900

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	95	$22,145
2016	N/R	68	$24,893
2017	N/R	34	$22,198
2018	N/R	42	$665
2019	N/R	N/R	N/R
2020	N/R	11	$287
2021	N/R	27	$419
2022	N/R	53	$803
2023	N/R	30	$497
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	517	1,022	$96
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	112	118	$62
95165	Professional service for preparation and provision of 1 or more antigens	186	5,342	$11
95117	Professional service for multiple injections of allergen	120	1,746	$9
95115	Professional service for single injection of allergen	138	1,814	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xeljanz Xr	Tofacitinib Citrate	61	1,890	$382,375
Cimzia (2 Pack)	Certolizumab Pegol	52	1,868	$361,730
Enbrel Mini	Etanercept	32	896	$239,715
Rinvoq	Upadacitinib	34	1,080	$239,042
Enbrel	Etanercept	22	626	$162,886

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	151	$3,414	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	172	$397,870	ABBVIE INC.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Michael D. Kohen, M.D.?

Tedicare shows public-source Medicare data for Michael D. Kohen, M.D. (NPI 1013909951), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael D. Kohen, M.D. have ACO affiliation data?

Michael D. Kohen, M.D. is shown with ACO affiliation data for Caravan Health ACO 50 LLC (MSSP, ACO ID A5160).

What billing organization is linked to Michael D. Kohen, M.D.?

Michael D. Kohen, M.D. is linked to MICHAEL D. KOHEN, MD, PA (billing NPI 1679772446) in the available physician profile data.

Does Michael D. Kohen, M.D. have Open Payments data?

Michael D. Kohen, M.D. has 323 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.